← Leaderboards
Kimberly G. Wagoner
Wake Forest University Health Sciences
$4,005,739
Attributed
$5,292,442
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,292,442 · 5
By mechanism
R01$2,287,873 · 1
U01$1,930,054 · 1
P01$842,015 · 2
R03$232,500 · 1
Top collaborators
- Beth A. Reboussin3 shared
- E. Alfonso Romero-Sandoval3 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Fadel Zeidan$4,813,065
- Stephanie S Daniel$4,634,447
- E. Alfonso Romero-Sandoval$4,456,103
- Beth A. Reboussin$6,433,141
- Thomas A Arcury$19,341,673
Others in their field
Other Emerging Leaders on “Vaping”
- Jessica Louise Barrington-Trimis · University Of Southern California$5,501,241
- Andy Sl Tan · University Of Pennsylvania$4,443,340
- Noel Todd Brewer · Univ Of North Carolina Chapel Hill$3,888,574
- Alayna Pauline Tackett · Ohio State University$3,787,593
- Arielle Ryan Baskin-Sommers · Yale University$3,522,373
- Denise Christina Vidot · University Of Miami Coral Gables$2,866,576
Research focus
VapingParticipantSurveysPrevalenceResearch PersonnelFutureMarketingEnvironmentPerceptionSamplingAdultHepatotoxicityRegulationBenefits And RisksPharmaceutical PreparationsReportingDrug PrescriptionsEnsureBehaviorInterestDrug AbuseDrug InteractionsMalignant NeoplasmsCoupled
Grant awards (12)
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics$640,613
U01 · FY2025 · CA
The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior$550,522
R01 · FY2025 · DA · contact PI
Core 2 - ARSC$267,237
P01 · FY2025 · CA · contact PI
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics$619,471
U01 · FY2024 · CA
Core 2 - ARSC$245,894
P01 · FY2024 · CA · contact PI
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics$669,970
U01 · FY2023 · CA
The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior$563,303
R01 · FY2023 · DA · contact PI
Core 2 - ARSC$328,884
P01 · FY2023 · CA · contact PI
The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior$610,751
R01 · FY2022 · DA · contact PI
The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior$563,297
R01 · FY2021 · DA · contact PI
Consumer Perceptions of Health Claims in Vape Shops$116,250
R03 · FY2018 · CA · contact PI
Consumer Perceptions of Health Claims in Vape Shops$116,250
R03 · FY2017 · CA · contact PI